The Mary Crowley Cancer Research Center is a national leader in cancer research with a clearly defined program and commitment to excellence to dramatically alter strategies of cancer treatment. Our mission is to pioneer personalized options for all cancer patients through gene-targeted therapies, cell based therapies, and vaccines.
At Mary Crowley we believe we are involved in a paradigm shift in cancer care, in which personalized molecular medicine will ultimately transform the way patients are treated. Mary Crowley, through our research focus and patient-centric care model, has implemented over 140 FDA approved clinical trials, with more than 300 investigational agents, resulting in hundreds of peer-reviewed publications. Thousands of patients have participated in investigational studies at Mary Crowley.
At Mary Crowley we believe in HOPE.